UnitedHealth Group (UNH) has seen a significant recovery in 2026, driven by a robust Q1 earnings report that exceeded analyst expectations. The company reported an adjusted EPS of $7.23, surpassing the estimated $6.59, and revenue of $111.7 billion, beating the forecasted $109.4 billion. The Medical Care Ratio improved to 83.9%, indicating better profitability. Following these results, UNH's stock has surged 23.76% over the past 30 days, trading at approximately $384 as of May 9, 2026. The earnings beat has led to increased confidence among investors, with JPMorgan raising its price target to $420. Additionally, UNH announced a $2 billion share buyback to be completed by the end of Q2 2026. The stock's technical recovery is supported by reclaiming the 50-week moving average, with the next target being the 100-week moving average at $420.87. If UNH maintains its momentum, it could reach the Potential Reversal Zone at $563.98, marking a potential 46.9% increase from current levels.